The abstract is read at the publisher; the summary is JClub's.
In a multicenter cohort of 6,049 nonmetastatic nasopharyngeal carcinoma patients treated with IMRT, TNM-9 improved prognostic performance over TNM-8 but left T- and N-category discrimination limited.
- Why it matters: TNM-9 has been adopted for NPC, yet its imaging-based T and N stratification shows imbalanced category sizes and weak survival separation, motivating refinement.
- What they did: Using pretreatment MRI, investigators restaged TNM-8 to TNM-9 and tested ESBI, CNFI, and grade 2 imaging-detected extranodal extension (G2-iENE) with multivariable Cox models and Groome’s criteria.
- The result: Reclassifying T3_ESBI to T2, T3_CNFI to T4, and N1_G2-iENE to N2 improved hazard discrimination and sample balance versus TNM-9, with 5-year OS for T2 vs T3 at 90.0% vs 88.0% (p = 0.006).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.